EUVIMEDEUVIMED entdecken
Crossref

Cardiovascular remodelling in patients with pre-dialysis chronic kidney disease and renal transplant recipients

Ramajana Temimović, Senija Rašić, Alen Džubur

Medicinski Glasnik · 2019

DOI: 10.17392/1009-19 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicinski Glasnik, 2019. Verfasst von Ramajana Temimović und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Occupational Medicine of Canton Sarajevo, Sarajevo, Bosnia and Herzegovina. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

<p><strong>Aim</strong> <br />To evaluate the relationship between cardiovascular remodelling and glomerular filtration rate (eGFR) in pre-dialysis chronic kidney disease (CKD) patients without cardiovascular diseases (CVD) and in renal transplant recipients (RTR). <br /><strong>Methods<br /></strong> The cross-sectional study included 83 patients with eGFR&lt;60 mL/min/1.73m 2 (45 with CKD 3 stage and 38 with CKD 4 stage). Thirty six RTR had eGFR 67.8 (57.3-73.7) mL/ min/1.73m 2 and control group consisted of 44 patients with eGFR&gt;60 mL/min/1.73m 2. All patients were evaluated by echocardiography and X-ray. <br /><strong>Results<br /></strong> Left ventricular hypertrophy (LVH) was present in 74.7% CKD patients, most frequently in CKD 4 stage and in RTR. Calcifications of abdominal aorta (CAA) were present in 87% CKD 4, 60% RTR and in 44% CKD 3 patients. Calcifications of the mitral valve were found in 34.2% CKD 4, 25.0% RTR and in 6.7% CKD 3 stage patients. Aortic valve calcifications were most frequently present in CKD 4 stage (26.3%). The LV mass index negatively correlated with eGFR (p&lt;0.001), and positively with parathyroid hormone (p&lt;0.001), phosphorus (p=0.043), age (p&lt;0.001) and diabetes (p=0.043). In multivariate regression analysis the risk factor for calcifications of the mitral and aortic valve, as well as for CAA was the decline in eGFR (p&lt;0.001). <br /><strong>Conclusion<br /></strong> Renal transplant recipients have a higher incidence of CV remodelling than patients with CKD 3 and less than patients with CKD 4 stage, indicating incomplete regression of CV calcifications and LVH after kidney transplantation. A decrease of renal function represents a significant risk factor for valvular and vascular calcifications occurrence in CKD patients.</p>

Schlagwörter

Stichwörter der Autor:innen

chronic kidney diseaseechocardiographyremodellingtransplantationvascular calcification

Autor:innen und Institutionen

  • Institute for Occupational Medicine of Canton Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Clinic for Nephrology, Clinical Centre of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Clinic for Heart Disease, Blood Vessels and Rheumatism, Clinical Centre of the University of Sarajevo; Sarajevo, Bosnia and Herzegovina.

Zitieren

APA

Temimović, R., Rašić, S., & Džubur, A. (2019). Cardiovascular remodelling in patients with pre-dialysis chronic kidney disease and renal transplant recipients. Medicinski Glasnik. https://doi.org/10.17392/1009-19

Vancouver

Temimović R, Rašić S, Džubur A. Cardiovascular remodelling in patients with pre-dialysis chronic kidney disease and renal transplant recipients. Medicinski Glasnik. 2019. doi:10.17392/1009-19

BibTeX
@article{Temimovi2019,
  author = {Temimović, Ramajana and Rašić, Senija and Džubur, Alen},
  title = {Cardiovascular remodelling in patients with pre-dialysis chronic kidney disease and renal transplant recipients},
  journal = {Medicinski Glasnik},
  year = {2019},
  doi = {10.17392/1009-19}
}
Kostenlos starten →